These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 1420815

  • 1. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
    Gjønnaess E, Solum NO, Brosstad F.
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
    [Abstract] [Full Text] [Related]

  • 2. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J.
    J Clin Invest; 1993 Jan; 91(1):273-82. PubMed ID: 8423224
    [Abstract] [Full Text] [Related]

  • 3. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
    Girma JP, Takahashi Y, Yoshioka A, Diaz J, Meyer D.
    Thromb Haemost; 1990 Oct 22; 64(2):326-32. PubMed ID: 1702906
    [Abstract] [Full Text] [Related]

  • 4. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions.
    Rivera J, Escolar G, Casamiquela R, Bravo MI, Jorquera JI, Castillo R, Ordinas A, Vicente V.
    Haematologica; 1999 Jan 22; 84(1):5-11. PubMed ID: 10091386
    [Abstract] [Full Text] [Related]

  • 5. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR, Williams SB, McKeown LP, Rick ME, Maisonneuve P, Jenneau C, Sultan Y.
    J Clin Invest; 1985 Oct 22; 76(4):1522-9. PubMed ID: 2932469
    [Abstract] [Full Text] [Related]

  • 6. Binding of a novel 50-kilodalton alboaggregin from Trimeresurus albolabris and related viper venom proteins to the platelet membrane glycoprotein Ib-IX-V complex. Effect on platelet aggregation and glycoprotein Ib-mediated platelet activation.
    Andrews RK, Kroll MH, Ward CM, Rose JW, Scarborough RM, Smith AI, López JA, Berndt MC.
    Biochemistry; 1996 Sep 24; 35(38):12629-39. PubMed ID: 8823201
    [Abstract] [Full Text] [Related]

  • 7. Crotalin, a vWF and GP Ib cleaving metalloproteinase from venom of Crotalus atrox.
    Wu WB, Peng HC, Huang TF.
    Thromb Haemost; 2001 Dec 24; 86(6):1501-11. PubMed ID: 11776320
    [Abstract] [Full Text] [Related]

  • 8. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
    De Marco L, Mazzucato M, De Roia D, Casonato A, Federici AB, Girolami A, Ruggeri ZM.
    J Clin Invest; 1990 Sep 24; 86(3):785-92. PubMed ID: 2394830
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
    Zucker MB, Puszkin EG, Sussman II, Mauss EA.
    J Lab Clin Med; 1990 Sep 24; 116(3):305-14. PubMed ID: 2401846
    [Abstract] [Full Text] [Related]

  • 10. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
    Clezardin P, Drouin J, Morel-Kopp MC, Hanss M, Kehrel B, Serre CM, Kaplan C, Delmas PD.
    Cancer Res; 1993 Oct 01; 53(19):4695-700. PubMed ID: 7691402
    [Abstract] [Full Text] [Related]

  • 11. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
    Takahashi H, Shibata A.
    Thromb Haemost; 1984 Dec 29; 52(3):267-70. PubMed ID: 6241752
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease.
    Tout H, Obert B, Houllier A, Fressinaud E, Rothschild C, Meyer D, Girma JP.
    Thromb Haemost; 2000 Feb 29; 83(2):274-81. PubMed ID: 10739386
    [Abstract] [Full Text] [Related]

  • 15. Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on von Willebrand factor binding to platelets.
    Yoshida E, Fujimura Y, Miura S, Sugimoto M, Fukui H, Narita N, Usami Y, Suzuki M, Titani K.
    Biochem Biophys Res Commun; 1993 Mar 31; 191(3):1386-92. PubMed ID: 8466514
    [Abstract] [Full Text] [Related]

  • 16. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK, Booth WJ, Gorman JJ, Castaldi PA, Berndt MC.
    Biochemistry; 1989 Oct 17; 28(21):8317-26. PubMed ID: 2557900
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.